Natco Pharma Limited has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.
- Read more about NATCO seeks Emergency approval of Molnupiravir capsules for Covid-19 treatment
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/natco-seeks-emergency-approval-of-molnupiravir-capsules-for-covid-19-treatment
No comments:
Post a Comment